Cullinan Oncology stock rises after FDA Fast Track designation for leukemia drug

view original post

Investing.com — Cullinan Therapeutics (NASDAQ:CGEM) stock rose 2.9% in Monday’s premarket trading after the company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track …